EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neuroinflammation, Blood–Brain Barrier, and HIV Reservoirs in the CNS: An In-Depth Exploration of Latency Mechanisms and Emerging Therapeutic Strategies

Noor Said, Vishwanath Venketaraman iD

Viruses · 16.04.2025 · 17 (4) · 572

DOI: 10.3390/v17040572 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 16.04.2025. Verfasst von Noor Said und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766-1854, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Virus Latency, HIV Infections, Neuroinflammatory Diseases. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH-NHLBI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the success of antiretroviral therapy (ART) in suppressing viral replication in the blood, HIV persists in the central nervous system (CNS) and causes chronic neurocognitive impairment, a hallmark of HIV-associated neurocognitive disorders (HAND). This review looks at the complex interactions among HIV, the blood–brain barrier (BBB), neuroinflammation, and the roles of viral proteins, immune cell trafficking, and pro-inflammatory mediators in establishing and maintaining latent viral reservoirs in the CNS, particularly microglia and astrocytes. Key findings show disruption of the BBB, monocyte infiltration, and activation of CNS-resident cells by HIV proteins like Tat and gp120, contributing to the neuroinflammatory environment and neuronal damage. Advances in epigenetic regulation of latency have identified targets like histone modifications and DNA methylation, and new therapeutic strategies like latency-reversing agents (LRAs), gene editing (CRISPR/Cas9), and nanoparticle-based drug delivery also offer hope. While we have made significant progress in understanding the molecular basis of HIV persistence in the CNS, overcoming the challenges of BBB penetration and neuroinflammation is key to developing effective therapies. Further research into combination therapies and novel drug delivery systems will help improve outcomes for HAND patients and bring us closer to a functional cure for HIV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierVirus LatencyHIV InfectionsNeuroinflammatory DiseasesHIV-1Central Nervous SystemHumansAnimalsDisease Reservoirs

Stichwörter der Autor:innen

HANDHIVblood–brain barrierdrug deliverygene editinginflammasomelatency-reversing agentsnanoparticlesreservoirs

Autor:innen und Institutionen

  • College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766-1854, USA.

ORCID-Profile: Vishwanath Venketaraman

Förderung

  • NHLBI NIH HHS
  • NIH-NHLBI

Zitieren

APA

Said, N., & Venketaraman, V. (2025). Neuroinflammation, Blood–Brain Barrier, and HIV Reservoirs in the CNS: An In-Depth Exploration of Latency Mechanisms and Emerging Therapeutic Strategies. Viruses, 17(4), 572. https://doi.org/10.3390/v17040572

Vancouver

Said N, Venketaraman V. Neuroinflammation, Blood–Brain Barrier, and HIV Reservoirs in the CNS: An In-Depth Exploration of Latency Mechanisms and Emerging Therapeutic Strategies. Viruses. 2025;17(4):572. doi:10.3390/v17040572

BibTeX
@article{Said2025,
  author = {Said, Noor and Venketaraman, Vishwanath},
  title = {Neuroinflammation, Blood–Brain Barrier, and HIV Reservoirs in the CNS: An In-Depth Exploration of Latency Mechanisms and Emerging Therapeutic Strategies},
  journal = {Viruses},
  year = {2025},
  volume = {17},
  number = {4},
  pages = {572},
  doi = {10.3390/v17040572}
}
Kostenlos starten →